| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Monday - Dec 11, 2023 |
|||||||||
| Q2 FY24 | $1.34 | $1.32 | $12.94B | $13.05B |
NYSE |
||||
|
Casey's General Stores
CASY
|
- | $4.24 | $3.80 | $4.06B | $4.06B |
NASDAQ |
|||
|
Blue Bird
BLBD
|
Q4 FY23 | $0.66 | $0.48 | $302.96M | $290.11M |
NASDAQ |
|||
|
Inotiv
NOTV
|
Q4 FY23 | -$0.38 | $0.11 | $140.70M | $139.43M |
NASDAQ |
|||
|
Oil-Dri of America
ODC
|
- | $0.75 | - | $111.44M | - |
NYSE |
|||
|
Tekla Life Sciences Investors
HQL
|
- | -$0.43 | - | $29.56M | - |
NYSE |
|||
|
Timberland Bancorp
TSBK
|
- | $0.81 | - | $23.50M | - |
NASDAQ |
|||
|
AMREP
AXR
|
- | $0.21 | - | $8.85M | - |
NYSE |
|||
|
OFS Credit
OCCI
|
- | $0.62 | $0.28 | $9.08M | $7.21M |
NASDAQ |
|||
|
Elevai Labs
ELAB
|
- | -$918.70 | - | $554.65K | - |
NASDAQ |
|||
|
Lexeo Therapeutics
LXEO
|
- | -$12.36 | -$2.60 | - | - |
NASDAQ |
|||
| Show 1 more companies | |||||||||
